Regulations.gov document
E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft…
Notice · FDA-2024-D-5601 · posted Mar 13, 2025
Key facts
| Document ID | FDA-2024-D-5601-0016 |
|---|---|
| Title | E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Reopening of the Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2024-D-5601 |
| Posted | Mar 13, 2025 |
| Federal Register citation | 90 FR 11985 |
| FR document number | 2025-04026 |
| Comment period opens | Mar 13, 2025 |
| Effective date | Mar 13, 2025 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: